SyntekaBio Adjusts Conversion Price for 4th CB from 3,720 KRW to 3,473 KRW, Increasing Convertible Shares
SyntekaBio adjusted the conversion price of its 4th unregistered private convertible bond from 3,720 KRW to 3,473 KRW due to a decline in market price.
This adjustment increases the number of convertible shares from 2,688,172 to 2,879,355, adding approximately 191,000 shares and slightly expanding potential dilution.
However, the adjusted conversion price of 3,473 KRW is still 85% above the current stock price of 1,872 KRW, making immediate conversion unlikely.
[AI Summary]The downward conversion price adjustment raises potential equity dilution risk, but the conversion price remains significantly above market price, limiting short-term impact. This is a contractual adjustment unrelated to management intent, and serves as a monitoring factor for investors.